{
    "Trade/Device Name(s)": [
        "UniCel DxC SYNCHRON Systems Hemoglobin A1c- (HbA1c-) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K121492",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010748"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "KRZ"
    ],
    "Summary Letter Date": "August 14, 2012",
    "Summary Letter Received Date": "August 15, 2012",
    "Submission Date": "September 7, 2012",
    "Regulation Number(s)": [
        "21 CFR 864.7470",
        "21 CFR 864.8165"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Calibrator for Hemoglobin or hematocrit measurement"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "UniCel DxC 600 SYNCHRON Systems",
        "UniCel DxC 800 SYNCHRON Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric immunoinhibition",
        "Colorimetric"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Immunoinhibition",
        "Colorimetry"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for UniCel DxC SYNCHRON Systems Hemoglobin A1c- Reagent for quantitative measurement of HbA1c in whole blood using turbidimetric immunoinhibition and colorimetric methods",
    "Indications for Use Summary": "Intended for the quantitative determination of hemoglobin A1c concentration in human whole blood, used for long-term glycemic control monitoring in patients with diabetes mellitus",
    "fda_folder": "Hematology"
}